US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Post-market: 308.600.2700+0.09%19:56 EDT

Volume:355.16K

Turnover:107.82M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.72%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Cardinal Health (CAH) and Allogene Therapeutics (ALLO)

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

HAIXI PHARMA Gains US FDA Fast Track Status for Lead Candidate Targeting Wet AMD

Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101

Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) and Demant (OtherWILLF)

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)

Trian takes boosts stakes in GE Healthcare, Wendy’s

Lupin Lupin Gets U.S. FDA Final Approval for Pitolisant Tablets

MT Newswires Live

OncoSil Flags FDA Milestone While Stressing Investor Caution

Radiopharm Theranostics to Meet With US FDA on Phase 3 Brain Metastases Diagnosis Trial

MT Newswires Live

OUE Healthcare Opens Flagship Prince Bay Hospital in Shenzhen’s Greater Bay Area

Radiopharm lines up FDA meeting to advance RAD101 brain metastasis imaging into Phase 3

160 Health Signals Profit Turnaround on Surge in Digital Healthcare Business

Nearly 1.6 Million Eggs Recalled in Southern US Due to Salmonella, FDA Flags Highest Risk

Indonesia Plans 'Flying Doctors' to Expand Healthcare Access in Remote Areas

The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":355161,"hourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Not Yet Opened","change":-8.87,"latestTime":"08-24 16:00:00 EDT","open":314.79,"high":315.4,"low":293,"amount":107824162.61835,"amplitude":0.070618,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003292,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"volumeRatio":0.701444,"impliedVol":0.977,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.701444,"shares":2124486,"dividePrice":1.015,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"eps":0,"divideRate":0.003292,"volume":355161,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660510480","title":"Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Cardinal Health (CAH) and Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660510480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660510480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:40","pubTimestamp":1786970438,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Silence Therapeutics (SLN), Cardinal Health (CAH) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-silence-therapeutics-sln-cardinal-health-cah-and-allogene-therapeutics-allo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-silence-therapeutics-sln-cardinal-health-cah-and-allogene-therapeutics-allo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0211328371.USD","HCSG","BK4585","XLV","LU0889566641.SGD","LU0310800965.SGD","LU0310799852.SGD","LU1267930813.SGD","LU1267930227.SGD","LU0029874061.USD","LU0154236417.USD","LU1880398471.USD","BK4588","LU0052756011.USD","LU0006061336.USD","LU0211327993.USD","SG9999001440.SGD","LABU","LU1571399168.USD","BK4581","BK4505","CAH","XBI","LU0072461881.USD","LU0162691827.USD","LU1880398554.USD","LU1267930490.SGD","BK4175","ALLO","LU0792757196.USD","LU1983299246.USD","BK4139","SLN","BK4137","LU0128525689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487002","title":"Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487002","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487002?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969800,"startTime":"0","endTime":"0","summary":"Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearanceNEW YORK, Aug.  17, 2026 (GLOBE NEWSW","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3346081/0/en/intelligent-bio-solutions-strengthens-quality-management-credentials-with-iso-recertification.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144208033","title":"HAIXI PHARMA Gains US FDA Fast Track Status for Lead Candidate Targeting Wet AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=1144208033","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144208033?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:54","pubTimestamp":1786967655,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) has announced that its independently developed innovative drug candidate, HX9428, from the HXP056 project, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1191","LABU","BK4585","02637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482660","title":"Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482660","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482660?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:40","pubTimestamp":1786966835,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) announced that it has scheduled an End-of-Phase 2 meeting with the FDA for October 1, to align on the design of a pivotal Phase 3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-schedules-end-of-phase-2-meeting-with-fda-for-rad101-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-schedules-end-of-phase-2-meeting-with-fda-for-rad101-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","RADX","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660826694","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) and Demant (OtherWILLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660826694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660826694?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:40","pubTimestamp":1786966813,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-achieve-life-sciences-achv-mereo-biopharma-group-plc-mreo-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-achieve-life-sciences-achv-mereo-biopharma-group-plc-mreo-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MREO","BK4505","BK4581","HCSG","XLV","ACHV","BK4139","XBI","LU0029874061.USD","LABU","BK4588","BK4585","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487966","title":"Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487966?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:30","pubTimestamp":1786966200,"startTime":"0","endTime":"0","summary":"RAD 101 Phase 2b trial demonstrated 93% concordance with MRI across all evaluable lesions, meeting the Phase 2 trial's primary endpoint End-of-Phase 2 meeting with the U.S. FDA scheduled for October 1","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3345992/0/en/radiopharm-theranostics-to-meet-with-u-s-fda-to-align-on-pivotal-phase-3-trial-design-for-rad-101-in-diagnosis-of-brain-metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RADX","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484873","title":"Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484873","media":"Dow Jones","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484873?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:00","pubTimestamp":1786964400,"startTime":"0","endTime":"0","summary":"Key recent and second quarter highlights include:-- Completed first-cycle FDA review of the Company's ANDA for. preservative-free ketamine with no drug-related major deficiencies. The. sole remaining item, a manufacturer's attestation on the vial, has been. -- Initiation of commercial scale manufacturing of preservative-free. ketamine building to launch stock of 5 million doses to be ready for. -- Selected by the Defense Advanced Research Projects Agency  as. prime contractor for SPARC-TMS, an FDA-approved Phase 2/3 trial of. NRX-101 with robotic TMS. Anticipated non-dilutive funding exceeds $11.5. -- The Company is advancing its NRX-100 NDA on Real World Evidence from more. than 65,000 patients, leveraging a Presidential Executive Order and. Congressional budget language that encourage FDA use of such evidence in. -- Closed an institutionally-supported, underwritten public offering of. common stock for gross proceeds of $22.3 million, including full exercise. of the underwriters' opti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UMI","BK4007","BK4144","BK4588","PSIL","MDST","AMZA","EIPX","LCLG","NQmain","BK4022","BK4561","BK4581","AMLP","NRXP","EMLP","EIPI","BK4590","TNGY","BK4232","R","MLPA","TPZ","LABU","USAI","ENFR","ET","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048525","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048525?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:01","pubTimestamp":1786957287,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Phathom Pharmaceuticals (PHAT) and BioMarin Pharmace...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PHAT","HCSG","IE00B19Z3B42.SGD","BK4588","XBI","BK4137","BMRN","IE00B19Z3581.USD","IE0002270589.USD","LABU","BK4139","XLV","IE00B7SZLL34.SGD","BK4581","BK4566","BK4585","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660485889","title":"Trian takes boosts stakes in GE Healthcare, Wendy’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2660485889","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660485889?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:42","pubTimestamp":1786956142,"startTime":"0","endTime":"0","summary":"Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of June 30, 2026. Trian increased its stake in two holdings, includ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trian-takes-boosts-stakes-in-ge-healthcare-wendys-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trian-takes-boosts-stakes-in-ge-healthcare-wendys-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","GE","XLV","LU1280957306.USD","LU1119994496.HKD","LU1064131342.USD","LU1261432733.SGD","MISL","BK4585","LU1366192091.USD","UXI","LU0820562030.AUD","LU0689472784.USD","BK4187","LU2087625088.SGD","LU0354030511.USD","LU0354030438.USD","LU2168563687.JPY","LU0267386448.USD","EXI","LU2168564065.EUR","LU2756315664.SGD","XBI","BK4543","LU1084165304.USD","LU1551013425.SGD","LU0029874061.USD","LU0943347566.SGD","LU0640476718.USD","ITA","BK4501","LU0353189763.USD","LU0077335932.USD","BK4581","XAR","LU2264538146.SGD","BK4206","LU0868494617.USD","NATO","LU0149725797.USD","DFEN","LU0820561909.HKD","PPA","TRUI","LU2168564149.EUR","LU0820561818.USD","LU2543165471.USD","LU1093756168.USD","HCSG","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660648807","title":"Lupin Lupin Gets U.S. FDA Final Approval for Pitolisant Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2660648807","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660648807?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:14","pubTimestamp":1786954473,"startTime":"0","endTime":"0","summary":"Lupin  said the U.S. Food and Drug Administration granted final approval for its abbreviated new drug application for Pitolisant Tablets 4.45 mg and 17.8 mg, according to a filing to Indian bourses.The tablets have been approved as bioequivalent to Wakix, which is approved in the U.S. for the treatment of narcolepsy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660023341","title":"OncoSil Flags FDA Milestone While Stressing Investor Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2660023341","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660023341?lang=en_us&edition=fundamental","pubTime":"2026-08-17 13:22","pubTimestamp":1786944148,"startTime":"0","endTime":"0","summary":"An update from OncoSil Medical Ltd ( ($AU:OSL) ) is now available. OncoSil Medical has prepared an investor webinar titled “FDA Approval: A New Cha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncosil-flags-fda-milestone-while-stressing-investor-caution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncosil-flags-fda-milestone-while-stressing-investor-caution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101432","title":"Radiopharm Theranostics to Meet With US FDA on Phase 3 Brain Metastases Diagnosis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101432","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101432?lang=en_us&edition=fundamental","pubTime":"2026-08-17 11:33","pubTimestamp":1786937616,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics  will meet with the US Food and Drug Administration  on Oct. 1 to seek alignment on the design of a phase 3 trial to evaluate its RAD101 imaging agent in patients with suspected recurrence of brain metastases following radiotherapy, according to a Monday filing with the Australian bourse.The meeting will focus on the trial's design criteria, including the number of patients to be enrolled and the primary and secondary endpoints, per the filing.The FDA will also review data from a phase 2b trial of RAD 101, which showed 93% concordance between MRI and PET imaging of brain metastases in the targeted patient population, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK7067","RAD.AU","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660510516","title":"OUE Healthcare Opens Flagship Prince Bay Hospital in Shenzhen’s Greater Bay Area","url":"https://stock-news.laohu8.com/highlight/detail?id=2660510516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660510516?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:42","pubTimestamp":1786927334,"startTime":"0","endTime":"0","summary":"OUE Lippo Healthcare Limited ( ($SG:5WA) ) has provided an update. OUE Healthcare’s joint venture has officially opened the Shenzhen China Merchant...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oue-healthcare-opens-flagship-prince-bay-hospital-in-shenzhens-greater-bay-area?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oue-healthcare-opens-flagship-prince-bay-hospital-in-shenzhens-greater-bay-area?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4209","BK4581","XBI","BK4585","XLV","BK4588","SG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660030071","title":"Radiopharm lines up FDA meeting to advance RAD101 brain metastasis imaging into Phase 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2660030071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660030071?lang=en_us&edition=fundamental","pubTime":"2026-08-17 07:37","pubTimestamp":1786923478,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics Limited ( ($AU:RAD) ) has issued an update. Radiopharm Theranostics has scheduled an End-of-Phase 2 meeting with the U.S. F...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/radiopharm-lines-up-fda-meeting-to-advance-rad101-brain-metastasis-imaging-into-phase-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/radiopharm-lines-up-fda-meeting-to-advance-rad101-brain-metastasis-imaging-into-phase-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659723581","title":"160 Health Signals Profit Turnaround on Surge in Digital Healthcare Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2659723581","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659723581?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:37","pubTimestamp":1786876674,"startTime":"0","endTime":"0","summary":"160 Health International Ltd. ( ($HK:2656) ) has issued an announcement. 160 Health International has issued a positive profit alert, indicating it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/160-health-signals-profit-turnaround-on-surge-in-digital-healthcare-business?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/160-health-signals-profit-turnaround-on-surge-in-digital-healthcare-business?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4137","HCSG","BK4585","BK4588","LU0128526141.USD","LU0029874061.USD","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180307109","title":"Nearly 1.6 Million Eggs Recalled in Southern US Due to Salmonella, FDA Flags Highest Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=1180307109","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180307109?lang=en_us&edition=fundamental","pubTime":"2026-08-16 14:43","pubTimestamp":1786862586,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration (FDA) has escalated a recall involving nearly 1.6 million dozen eggs to its highest risk level (Class I) due to potential Salmonella contamination. The outbreak...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659171758","title":"Indonesia Plans 'Flying Doctors' to Expand Healthcare Access in Remote Areas","url":"https://stock-news.laohu8.com/highlight/detail?id=2659171758","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659171758?lang=en_us&edition=fundamental","pubTime":"2026-08-16 12:15","pubTimestamp":1786853702,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta- Indonesia's State Secretary Minister Prasetyo Hadi said the government’s “flying doctor” program would focus on improving access to healthcare in remote areas where medical facilities are difficult to reach, rather than providing the service in every village.Hadi was responding to a concept outlined by President Prabowo Subianto in his speech on the government’s proposed 2027 state budget and financial note at the Parliament Complex in Jakarta on Friday.“Why did the idea of flying doctors emerge? We use the term ‘flying’ because, on several occasions when we have traveled across Indonesia, we have seen that our country is very vast and access to healthcare facilities is still uneven,” he said at Merdeka Palace in Jakarta on Saturday.","market":"other","thumbnail":"https://statik.tempo.co/data/2014/10/13/id_333771/333771_620.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2014/10/13/id_333771/333771_620.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2117609/indonesia-plans-flying-doctors-to-expand-healthcare-access-in-remote-areas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2117609/indonesia-plans-flying-doctors-to-expand-healthcare-access-in-remote-areas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["VHT","BK4137","LABU","HCSG","XBI","LU0128526141.USD","BK4550","BK4585","LU0029874061.USD","XLV","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659171859","title":"The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2659171859","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659171859?lang=en_us&edition=fundamental","pubTime":"2026-08-16 09:21","pubTimestamp":1786843306,"startTime":"0","endTime":"0","summary":"In August 2026, Celcuity Inc. reported a wider Q2 net loss of US$78.86 million and higher basic loss per share, while securing FDA approval and a preferred Category 1 NCCN guideline recommendation for Revtopik in HR-positive, HER2-negative advanced breast cancer.\nAlongside the deeper losses, the combination of strong Phase 3 efficacy data and rapid guideline endorsement for Revtopik materially reshapes how Celcuity’s pipeline can translate into future commercial activity.\nWe’ll now examine...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/the-bull-case-for-celcuity-celc-could-change-following-revto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/the-bull-case-for-celcuity-celc-could-change-following-revto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4139","CELC","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659827176","title":"Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659827176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659827176?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:30","pubTimestamp":1786818607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DAR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HCSG","BK4581","LABU","XLV","BK4584","BK4588","LU0029874061.USD","BK4137","DIVL","BK4585","DINT","APIE","AADR","XBI","BLTE","DARE","LU0128526141.USD","ARMH","SAPH","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175749","title":"Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659175749?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:20","pubTimestamp":1786818008,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mediwound (MDWD) and Capricor Therapeutics (CAPR)....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","CAPR","MDWD","LU0128526141.USD","XBI","BK4007","BK4137","BK4581","LABU","LU0029874061.USD","BK4585","BK4139","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":12,"totalSize":401,"code":"91000000","status":"200"}]}}